A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome - Concepedia

Concepedia

Publication | Closed Access

A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome

72

Citations

36

References

2007

Year

Diego García‐Borreguero, Ronald R. Grunstein, Guruswamy Sridhar, Tilman Dreykluft, Pasquale Montagna, René Dom, Eric Lainey, Anne Moorat, J.T. Roberts

RheumatologyRestless LegsPharmacotherapy52-Week Open-label StudyLong-term SafetyMedicineAnesthesiology

References

	Year	Citations

Page 1